Institutional and Alternate-Site Drug Distribution
Hospitals, long-term care, and other sites
Institutional practice shifts the regulatory unit from the prescription to the medication order and from the individual pharmacist to the system. Hospitals operate under state licensure - in Pennsylvania, Department of Health hospital regulations - and CMS Conditions of Participation at 42 C.F.R. § 482.25, which require a pharmacy directed by a registered pharmacist, a formulary system with pharmacy and therapeutics oversight, drug distribution and accounting controls, and adverse drug reaction reporting. Orders are reviewed by a pharmacist before administration except in defined emergency situations; floor stock is limited; unit-dose distribution and automated dispensing cabinets require override controls, security, restocking accountability, and audit trails. Long-term care adds OBRA '87 requirements: a consultant pharmacist performing drug regimen review at least monthly, reporting irregularities to the medical director and attending physician, and attention to unnecessary drugs, antipsychotic use, and gradual dose reduction. Alternate sites - dialysis, ambulatory surgery, correctional, and mail-order pharmacies - each carry their own supervision and recordkeeping requirements. Emergency kits and after-hours access need documented controls, sealed kits, and reconciliation after use. Discharge counseling and medication reconciliation cross settings and are frequently examined.
Traps
Assuming hospital pharmacy is exempt from Board of Pharmacy rules; treating a physician's order as exempt from pharmacist review; forgetting the consultant pharmacist's reporting duty; assuming automated cabinets escape security and audit requirements; overlooking after-hours and emergency-kit accountability.
Rule of thumb
In any institutional setting, ask: who verified the order, who physically holds the drug, who reviews the therapy over time, and who documents it. If all four answers are clear, the system is likely compliant.